Pathological procedures to diagnose tumors include frozen sections of tissue during surgery, routine tissue sections examined microscopically using hematoxylin-eosin stain, and various types of biopsies. Additional diagnostic tools discussed are immunohistochemistry using monoclonal antibodies, DNA and RNA probes, electron microscopy, fluorescent microscopy, histochemical stains, blot assays extracting DNA and RNA from cells, and tumor markers. Modern techniques mentioned are flow cytometry, in situ hybridization, analysis of cell proliferation, image analysis and morphometry, and molecular diagnostic techniques including polymerase chain reaction and DNA microarrays.
The Acoustic Technology for Ctcs Isolation in Blood: Low-Cost Devices_Crimson...CrimsonpublishersCancer
Blood samples can be used as a liquid biopsy in cancer diagnosis and chemotherapy monitoring. This label- free method offers benefits over traditional tissue invasive biopsy. It is possible to separate rare cells from blood samples by Ultrasounds on the basis of their physical properties in a biocompatible manner. A successful separation of cultured cancer cells from WBCs with acoustic-based methods is being demonstrated during the last years through different technological approaches. The concept of plate acoustic waves (PAW) applied to acoustophoresis was recently introduced to perform acoustic flow-through separation of rare cells in blood samples. It lies in the geometrical chip design, different to other micro separators (BAW and SAW). This new strategy allows soft materials of extremely reduced volume and low-cost fabrication and opens a door to printing manufacturing processes.
The Acoustic Technology for Ctcs Isolation in Blood: Low-Cost Devices_Crimson...CrimsonpublishersCancer
Blood samples can be used as a liquid biopsy in cancer diagnosis and chemotherapy monitoring. This label- free method offers benefits over traditional tissue invasive biopsy. It is possible to separate rare cells from blood samples by Ultrasounds on the basis of their physical properties in a biocompatible manner. A successful separation of cultured cancer cells from WBCs with acoustic-based methods is being demonstrated during the last years through different technological approaches. The concept of plate acoustic waves (PAW) applied to acoustophoresis was recently introduced to perform acoustic flow-through separation of rare cells in blood samples. It lies in the geometrical chip design, different to other micro separators (BAW and SAW). This new strategy allows soft materials of extremely reduced volume and low-cost fabrication and opens a door to printing manufacturing processes.
Objective: To analyze the sonographic features of different histopathological subtypes of borderline ovarian tumors (BOTs) confirmed by pathology, and to study the ultrasound performances of various types in borderline ovarian tumors.
Study Design: Retrospective analysis was performed on the pathological results and ultrasound projection findings of 129 patients diagnosed as BOTs by ultrasound department of our hospital from January 2012 to November 2019. All patients were confirmed by surgical pathology and scanned consecutively by the investigators using transabdominal or transvaginal ultrasound examination.
Results: Serous borderline tumors (SBOTs) were observed, and the prevalence rate (53%) was significantly higher than that of other subtypes, and the probability of bilateral lesions was higher (40%). The sonogram often showed ultrasound features of papillary neoplasm in the lesion and good internal echo (p<0.05). Mucinous borderline ovarian tumors (MBOTs) were mostly unilateral lesions (86%). The prevalence was second only to SBOTs. Histomorphological examinations were divided into gastrointestinal-type and endocervical-type. Among them, the gastrointestinal type of MBOTs were mostly unilateral, and their incidence was higher than that of endocervical-type of MBOTs. Compared with other pathological subtypes, the gastrointestinal type is more likely to show the sonographic characteristics of huge space occupying in the pelvic and abdominal cavity (mean diameter >10 cm), polycystic, multiple septums, and poor internal echo (p<0.05). The ultrasonographic features of the endocervical-type of MBOTs were similar to those of SBOTs. Compared with gastrointestinal type, the sonographic images showed smaller lesion diameter, less septal or cyst, and more papillary excrescences in the tumor (p<0.05). The borderline clear cell tumor is the intermediate transition between the clear cell adenofibroma and the clear cell carcinoma. The clinical manifestations are diverse and lack specificity. The histology of sonography was mainly solid, and the multiple microcapsules were honeycomb-like. It can also be shown as cystic. Among the 169 patients with BOTs, 20 cases of SBOTs, 17 cases of MBOTs, and 10 cases of other rare subtypes were complicated with other diseases or multiple subtypes. This study did not find significant ultrasonic characteristics were used for distinguish them from other subtypes.
Conclusion: BOTs is a common disease in women during the reproductive period. It is characterized by the development of malignant tumors. Its clinical and pathological subtypes are complex and diverse. It leads many doctors to use the terms “large pelvic mass” and “solid ovarian mass” for diagnosis because of their lack of experience and understanding.
Keywords: adenocarcinoma, mucinous; adenocarcinoma, serous; borderline ovarian tumors; diagnostic imaging; ovarian neoplasms; papillary neoplasms; prognosis; transvaginal ultrasound, ultrasonography
Exosomes are 30-150 nm tiny vesicles secreted by most cell types in vivo and in vitro. They are found in all body fluids including plasma, serum, saliva, urine, amniotic fluid, malignant ascite fluids, and cultured medium of cell cultures. Exosomes contain various molecular constituents of their cell of origin, including proteins and RNA. Evidence has shown that exosomes act as many different roles and functions including eradication of obsolete molecules, intercellular communication, antigen presentation, dissemination of oncogenes from tumor cells, and spread of pathogens such as prions and viruses from one cell to another. https://www.creative-biolabs.com/exosome/services.htm
Exosomes have specialized functions and play a key role in different physiological processes and pathological conditions. Consequently, exosomes have attracted increasing attention in their clinical applications for prognosis,
https://www.creative-biolabs.com/exosome/applications.htm
Exosomes biomarkers mediating important biological process,especially in the systemic disease
diagnostics and therapeutics,yet the protective exosomal vesicle structure hinders rapid,simple detection of the harbored molecules.
Molecular characterization of a patient’s tumor to guide treatment decisions is increasingly being
applied in clinical care and can have a significant impact on disease outcome. These molecular analyses,
including mutation characterization, are typically performed on tissue acquired through a biopsy at diagnosis.
However, tumors are highly heterogeneous and sampling in its entirety is challenging. Furthermore, tumors
evolve over time and can alter their molecular genotype, making clinical decisions based on historical biopsy
data suboptimal. Personalized medicine for cancer patients aims to tailor the best treatment options for the
individual at diagnosis and during treatment. To fully enable personalized medicine it is desirable to have an
easily accessible, minimally invasive way to determine and follow the molecular makeup of a patient’s tumor
longitudinally. One such approach is through a liquid biopsy, where the genetic makeup of the tumor can be
assessed through a bio fluid sample. Liquid biopsies have the potential to help clinicians screen for disease,
stratify patients to the best treatment and monitor treatment response and resistance mechanisms in the tumor. A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature
allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. This review will summarize three approaches in the liquid biopsy field: circulating tumor cells (CTCs), cell free DNA (cfDNA) and exosomes. We also outline some of the analytical challenges encountered using liquid biopsy techniques to detect rare mutations in a background of wild-type sequences.
BACKGROUND: Sequential Epstein-Barr virus (EBV)–positive B cell lymphoma to the initial diagnosis of angioimmunoblastic T cell lymphoma (AITL) is very rare, the exact mechanism and standard therapy of which is still being explored. CASE: A 50-year-old man was admitted to our hospital in January 2014 with a three-week history of enlargement of multiple lymph nodes. His initial pathological evaluation indicated AILT. The reactivation of EBV was observed during the immunosuppression therapy for AITL, accompanied by onset of subcutaneous nodules proven to be EBV-positive diffuse large B cell lymphoma (DLBCL) based on the pathological findings of rebiopsy. The patient was successfully treated with chidamide, a histone deacetylase (HDAC) inhibitor, and rituximab.
Conclusion: The sufficient surveillance for serum EBV and repeat biopsy is necessary for patients with AITL, and this treatment modality may become an active option.
Keywords: angioimmunoblastic T cell lymphoma, Epstein-Barr virus, HDAC inhibitor, non-Hodgkin lymphoma, peripheral T cell lymphoma
Monoclonal Antibodies and it's applications.pptxAfroj Shaikh
SlideShare Description: Monoclonal Antibodies and Their Applications
In the rapidly advancing field of biotechnology, monoclonal antibodies have emerged as powerful tools with diverse applications. This SlideShare presentation provides a comprehensive overview of monoclonal antibodies and their wide-ranging uses in various fields, including medicine, research, and diagnostics.
The presentation begins by explaining the fundamental concept of monoclonal antibodies, highlighting their unique structure and production process. It delves into the significance of hybridoma technology, which allows for the generation of large quantities of identical antibodies derived from a single parental cell line.
Moving on, the SlideShare explores the applications of monoclonal antibodies in the field of medicine. It elucidates how these antibodies are employed in targeted therapies, such as cancer immunotherapy. The presentation highlights the remarkable specificity of monoclonal antibodies in recognizing and binding to specific targets, thereby enabling precise and tailored treatment approaches. It also discusses the role of monoclonal antibodies in autoimmune diseases, infectious diseases, and organ transplantation.
Furthermore, the presentation sheds light on the use of monoclonal antibodies in research and diagnostics. It explains how these antibodies are utilized as indispensable tools in laboratory research, facilitating the identification and characterization of various biomarkers and molecules. It also showcases their utility in techniques such as enzyme-linked immunosorbent assays (ELISA), flow cytometry, and immunohistochemistry.
The SlideShare emphasizes the impact of monoclonal antibodies on the development of novel therapeutic modalities, including antibody-drug conjugates and bispecific antibodies. It touches upon the challenges and future prospects in the field, highlighting ongoing research efforts and advancements in antibody engineering.
With visually appealing slides, concise and informative content, this SlideShare presentation on monoclonal antibodies provides a valuable resource for scientists, healthcare professionals, students, and anyone interested in understanding the significance and applications of these remarkable biotechnological innovations.
Objective: To analyze the sonographic features of different histopathological subtypes of borderline ovarian tumors (BOTs) confirmed by pathology, and to study the ultrasound performances of various types in borderline ovarian tumors.
Study Design: Retrospective analysis was performed on the pathological results and ultrasound projection findings of 129 patients diagnosed as BOTs by ultrasound department of our hospital from January 2012 to November 2019. All patients were confirmed by surgical pathology and scanned consecutively by the investigators using transabdominal or transvaginal ultrasound examination.
Results: Serous borderline tumors (SBOTs) were observed, and the prevalence rate (53%) was significantly higher than that of other subtypes, and the probability of bilateral lesions was higher (40%). The sonogram often showed ultrasound features of papillary neoplasm in the lesion and good internal echo (p<0.05). Mucinous borderline ovarian tumors (MBOTs) were mostly unilateral lesions (86%). The prevalence was second only to SBOTs. Histomorphological examinations were divided into gastrointestinal-type and endocervical-type. Among them, the gastrointestinal type of MBOTs were mostly unilateral, and their incidence was higher than that of endocervical-type of MBOTs. Compared with other pathological subtypes, the gastrointestinal type is more likely to show the sonographic characteristics of huge space occupying in the pelvic and abdominal cavity (mean diameter >10 cm), polycystic, multiple septums, and poor internal echo (p<0.05). The ultrasonographic features of the endocervical-type of MBOTs were similar to those of SBOTs. Compared with gastrointestinal type, the sonographic images showed smaller lesion diameter, less septal or cyst, and more papillary excrescences in the tumor (p<0.05). The borderline clear cell tumor is the intermediate transition between the clear cell adenofibroma and the clear cell carcinoma. The clinical manifestations are diverse and lack specificity. The histology of sonography was mainly solid, and the multiple microcapsules were honeycomb-like. It can also be shown as cystic. Among the 169 patients with BOTs, 20 cases of SBOTs, 17 cases of MBOTs, and 10 cases of other rare subtypes were complicated with other diseases or multiple subtypes. This study did not find significant ultrasonic characteristics were used for distinguish them from other subtypes.
Conclusion: BOTs is a common disease in women during the reproductive period. It is characterized by the development of malignant tumors. Its clinical and pathological subtypes are complex and diverse. It leads many doctors to use the terms “large pelvic mass” and “solid ovarian mass” for diagnosis because of their lack of experience and understanding.
Keywords: adenocarcinoma, mucinous; adenocarcinoma, serous; borderline ovarian tumors; diagnostic imaging; ovarian neoplasms; papillary neoplasms; prognosis; transvaginal ultrasound, ultrasonography
Exosomes are 30-150 nm tiny vesicles secreted by most cell types in vivo and in vitro. They are found in all body fluids including plasma, serum, saliva, urine, amniotic fluid, malignant ascite fluids, and cultured medium of cell cultures. Exosomes contain various molecular constituents of their cell of origin, including proteins and RNA. Evidence has shown that exosomes act as many different roles and functions including eradication of obsolete molecules, intercellular communication, antigen presentation, dissemination of oncogenes from tumor cells, and spread of pathogens such as prions and viruses from one cell to another. https://www.creative-biolabs.com/exosome/services.htm
Exosomes have specialized functions and play a key role in different physiological processes and pathological conditions. Consequently, exosomes have attracted increasing attention in their clinical applications for prognosis,
https://www.creative-biolabs.com/exosome/applications.htm
Exosomes biomarkers mediating important biological process,especially in the systemic disease
diagnostics and therapeutics,yet the protective exosomal vesicle structure hinders rapid,simple detection of the harbored molecules.
Molecular characterization of a patient’s tumor to guide treatment decisions is increasingly being
applied in clinical care and can have a significant impact on disease outcome. These molecular analyses,
including mutation characterization, are typically performed on tissue acquired through a biopsy at diagnosis.
However, tumors are highly heterogeneous and sampling in its entirety is challenging. Furthermore, tumors
evolve over time and can alter their molecular genotype, making clinical decisions based on historical biopsy
data suboptimal. Personalized medicine for cancer patients aims to tailor the best treatment options for the
individual at diagnosis and during treatment. To fully enable personalized medicine it is desirable to have an
easily accessible, minimally invasive way to determine and follow the molecular makeup of a patient’s tumor
longitudinally. One such approach is through a liquid biopsy, where the genetic makeup of the tumor can be
assessed through a bio fluid sample. Liquid biopsies have the potential to help clinicians screen for disease,
stratify patients to the best treatment and monitor treatment response and resistance mechanisms in the tumor. A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature
allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. This review will summarize three approaches in the liquid biopsy field: circulating tumor cells (CTCs), cell free DNA (cfDNA) and exosomes. We also outline some of the analytical challenges encountered using liquid biopsy techniques to detect rare mutations in a background of wild-type sequences.
BACKGROUND: Sequential Epstein-Barr virus (EBV)–positive B cell lymphoma to the initial diagnosis of angioimmunoblastic T cell lymphoma (AITL) is very rare, the exact mechanism and standard therapy of which is still being explored. CASE: A 50-year-old man was admitted to our hospital in January 2014 with a three-week history of enlargement of multiple lymph nodes. His initial pathological evaluation indicated AILT. The reactivation of EBV was observed during the immunosuppression therapy for AITL, accompanied by onset of subcutaneous nodules proven to be EBV-positive diffuse large B cell lymphoma (DLBCL) based on the pathological findings of rebiopsy. The patient was successfully treated with chidamide, a histone deacetylase (HDAC) inhibitor, and rituximab.
Conclusion: The sufficient surveillance for serum EBV and repeat biopsy is necessary for patients with AITL, and this treatment modality may become an active option.
Keywords: angioimmunoblastic T cell lymphoma, Epstein-Barr virus, HDAC inhibitor, non-Hodgkin lymphoma, peripheral T cell lymphoma
Monoclonal Antibodies and it's applications.pptxAfroj Shaikh
SlideShare Description: Monoclonal Antibodies and Their Applications
In the rapidly advancing field of biotechnology, monoclonal antibodies have emerged as powerful tools with diverse applications. This SlideShare presentation provides a comprehensive overview of monoclonal antibodies and their wide-ranging uses in various fields, including medicine, research, and diagnostics.
The presentation begins by explaining the fundamental concept of monoclonal antibodies, highlighting their unique structure and production process. It delves into the significance of hybridoma technology, which allows for the generation of large quantities of identical antibodies derived from a single parental cell line.
Moving on, the SlideShare explores the applications of monoclonal antibodies in the field of medicine. It elucidates how these antibodies are employed in targeted therapies, such as cancer immunotherapy. The presentation highlights the remarkable specificity of monoclonal antibodies in recognizing and binding to specific targets, thereby enabling precise and tailored treatment approaches. It also discusses the role of monoclonal antibodies in autoimmune diseases, infectious diseases, and organ transplantation.
Furthermore, the presentation sheds light on the use of monoclonal antibodies in research and diagnostics. It explains how these antibodies are utilized as indispensable tools in laboratory research, facilitating the identification and characterization of various biomarkers and molecules. It also showcases their utility in techniques such as enzyme-linked immunosorbent assays (ELISA), flow cytometry, and immunohistochemistry.
The SlideShare emphasizes the impact of monoclonal antibodies on the development of novel therapeutic modalities, including antibody-drug conjugates and bispecific antibodies. It touches upon the challenges and future prospects in the field, highlighting ongoing research efforts and advancements in antibody engineering.
With visually appealing slides, concise and informative content, this SlideShare presentation on monoclonal antibodies provides a valuable resource for scientists, healthcare professionals, students, and anyone interested in understanding the significance and applications of these remarkable biotechnological innovations.
Identification of Rare and Novel Alleles in FFPE Tumor Samples | ESHG 2015 Po...Thermo Fisher Scientific
Tumors are becoming recognized as genetically heterogeneous masses of cells with different clonal histories. Identifying the mutations present in these heterogeneous masses can lead to important insights into the future behavior of the tumor and possible intervention mechanisms. However, the rarity of pathogenic mutations in small subsets of cells can make identification of such alleles difficult. In this study, we demonstrate a complete workflow that facilitates the identification of rare and novel alleles from FFPE tumor sections. We collected small regions with different cellular morphologies from lung tumor samples using laser capture microdissection, extracted both DNA and RNA from these regions, and characterized mutations present and transcript abundances by using Ion AmpliSeq™ targeted sequencing. We show that LCM facilitates the detection of alleles that are not detectable in macrodissected tissue scrapes. We also show that different regions of a tumor have very different patterns of alleles detectable and have a great deal of genetic diversity. Finally, we show that RNA expression patterns are also clearly different in the different regions. Interestingly, dissected regions with similar gross tissue morphologies display differences in alleles present and RNA expression patterns. These results suggest how we may in the future use this method to analyze mutations present in a tumor is to microdissect different subregions of the tumor, and using Ion AmpliSeq™ panels to identify the alleles present in those subregions.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
1. LAB. Investigations / Diagnosis
Of
Tumours/ Cancers
• DR. U.S. PANDEY
• PROFESSOR & HOD,
• DEPTT OF PATHOLOGY,
• GOVT MEDICAL COLLEGE,
• BETTIAH-845438 (West Champaran
2. Pathological procedures that are used to diagnose tumors
include :
*1. Immediate Frozen Sections of tissue removed during
surgery: freeze the tissue, make thin sections on a
microtome, and stain in less than 3 minutes.
*2. Routine Tissue Sections (HISTO-pathology)-*usually use
hematoxylin-eosin stain.
* 3.Cytology (Needle Aspirations,Exfoliative Cyto), needle
biopsies, incisional biopsies (piece of the tumor),
excisional biopsies (entire lesion).
*4. Immunohistochemistry(IHC):
(use monoclonal antibodies against antigensin tissue
that can be identified as color changes in the tissue).
8. Examples of IHC staining at different sites in the tumour cells. A, Membranous staining for
leucocyte common antigen (LCA) or CD45 in lymphomas. B, Cytoplasmic staining for
smooth muscle actin (SMA) in myoepithelium on breast acinus. C, Nuclear staining for
breast ER-PR receptor studies in breast Cancer
9. *5. D N A - Probes
• Probe is any searching device for examination
or investigation in order to get information &
exploration.
Mol.Probe is a sequence of D.N.A. used to
identify a complementary sequence.
Types of Mol. Probe : of different Source & Size: are
1. Genomic Probe
2. c DNA-Probe
3. Oligonucleotide Probe
4. Ribo;Probe
5.Radioactive Labelled Probe ( 52p, 125I )
6.Non-Radioactive Labelled Probe (Biotin,Digoxigenin)
10. * 6.Electron Microscopy :
Ultrastructural examination of tumour cells offers selective role
in diagnostic pathology. A few general features of malignant
tumour cells by EM examination can be appreciated:
i) Cell junctions, their presence and type.
ii) Cell surface, e.g. presence of microvilli.
iii) Cell shape and cytoplasmic extensions.
iv) Shape of the nucleus and features of nuclear membrane.
v) Nucleoli, their size and density.
vi) Cytoplasmic organelles—their number is generally reduced.
vii) Dense bodies in the cytoplasm.
viii) Any other secretory product in the cytoplasm e.g.
melanosomes in melanoma and membrane-bound
granules in endocrine tumours.
11. * 6.Electron Microscopy(Contd.,) is useful in identifying
the following tumors:
. Epithelial tumor---- Tonofilaments
. Angiosarcoma - - - demonstration of Weibel Palade
--bodies.
. Small cell carcinoma of the lung, neuroblastomas and
carcinoid tumors - -
- - neurosecretory granules
. Rhabdomyosarcomas - - - thick and thin myofilaments
. Histiocytosis X (malignant histiocytic tumor) - - -
----BirbeckGranulesinLangerhan’scells(Histiocytes)
12. 7.Fluorescent Microscopy
• Dye-Acridine Orange gives Polychromatic Picture &
Differentiates D.N.A. of Nucleus from R.N.A. of Cytoplasm.
• Malignant Cells stain Red or Orange & Normal Cells Yellow
or Green . Drugs Tetracycline concentrate more in cancer
cells.Smallest Pinpoint of yellow fluorescence is evidence of
cancers in 50% cases.
Thus Cytoplasmic R.N.A. is earlier sign of malignancy,
useful in Ut. Cancer,GIT,Respiratory & Urogenital
Cancers, esp.,Sputum & Bronchial Secretions.
14. * 8..Histochemical Stains of importance include:
. Cytokeratin - - - separates a carcinoma (positive) from a
malignant lymphoma (negative) and a mesothelioma
(positive) from an adenocarcinoma (negative)
. S 100 - - -positive in malignant melanoma and
neuroblastomas
. Factor VIII related antigen - - - positive in vascular tumors.
. Carcinoembryonic antigen (CEA) - - - negative in
mesothelioma and positive in adenocarcinoma
. Desmin - - - positive in muscle sarcomas
* 9.Southern blot assays involve the extraction of DNA from
cells.
•10.Northern blot assays involve the extraction of RNA from
cells.
•11.Tumour Markers: e.g.,CEA,a-Fetoprotein,PAO,CA-125,CA-
19.9,PSA
17. Examples of IHC staining at different sites in the tumour cells. A, Membranous staining for
leucocyte common antigen (LCA) or CD45 in lymphomas. B, Cytoplasmic staining for
smooth muscle actin (SMA) in myoepithelium on breast acinus. C, Nuclear staining for
breast ER-PR receptor studies in breast Cancer
18. 10.Tumour Markers
Tumor marker may be defined as substance of
varying nature which may be tumor antigen or
other tumor products such as enzyme ,
hormones, immunoglobulin or
chromosomes,the determination of which
from blood ,urine or other accessible parts of
the body of patients ,may help in suggesion,
confirmation ,prognosis or recurrence of any
human neoplasm.
19. Types of tumor marker
1. Oncofetal Antigens
2. Hormones
3. Enzymes
4. Specific proteins
5. Cancer associated proteins
6. Other macromolecules
7. Immunoglobulin
8. Intermediate filaments
9. Virus
10. New markers
20.
21.
22.
23.
24.
25.
26. 11.OTHER MODERN AIDS IN PATHOLOGIC DIAGNOSIS OF TUMOURS
Other modern diagnostic techniques have emerged for tumour diagnostic
pathology but their availability as well as applicability are limited.
i) Flow cytometry This is a computerised technique by which the detailed characteristics
of individual tumour cells are recognised and quantified and the data can be
stored for subsequent comparison too.
ii) In situ hybridisation This is a molecular technique by which nucleic acid sequences
(cellular/viral DNA and RNA) can be localised by specifically-labelled nucleic acid
probe directly in the intact cell (in situ) rather than by DNA extraction.
iii) Cell proliferation analysis Besides flow cytometry, the degree of proliferation of cells in
tumours can be determined by various other methods e.g. Ki67
a) Mitotic count
b) Radioautography
c) Microspectrophotometric analysis
d) IHC proliferation markers
e) Nuclear Organiser Region ( NOR )
iv) Image analyzer and morphometry The system is used to perform measurement of
architectural, cellular and nuclear features of tumour cells.
v) Molecular diagnostic techniques: The group of molecular biologic methods in the tumour
diagnostic laboratory are a variety of DNA/RNA-based molecular techniques in
which the DNA/RNA are extracted (compared from in situ above) from the cell and
then analysed. Molecular diagnostic techniques include : DNA analysis by
Southernblot,RNA analysis by Northern blot , & PCR(Polymerase Chain
31. Molecular diagnosis:
MICRO-ARRAYS Analy
DNA microarray analysis:
• Expression of thousands of
genes are studied.
• Different tissue has
different pattern of gene
expression.
• Powerful tool useful for
sub categorization of disease
e.g. Lymphoma
- confirmation of
morphologic diagnosis
- illustration of genes
involved in certain disease
& possible therapy.